Covered recipient · General Payments record
ELIZA C CONTRERAS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$1,278.54
- Reported across 76 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $436.66 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $150.55 | 9 |
| Lilly USA, LLC | $104.27 | 7 |
| Exact Sciences Corporation | $46.72 | 3 |
| PFIZER INC. | $41.98 | 2 |
| ABBVIE INC. | $20.85 | 1 |
| Abbott Laboratories | $20.21 | 1 |
| Astellas Pharma US Inc | $20.04 | 1 |
| DEXCOM, INC. | $18.39 | 1 |
| GlaxoSmithKline, LLC. | $13.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.21 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125306417 | CMS |
| ABBVIE INC. | $20.85 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103498642 | CMS |
| Astellas Pharma US Inc | $20.04 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139267640 | CMS |
| Dexcom, Inc. | $18.39 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153298297 | CMS |
| Exact Sciences Corporation | $15.70 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114432589 | CMS |
| Exact Sciences Corporation | $15.70 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114432594 | CMS |
| Exact Sciences Corporation | $15.32 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114432597 | CMS |
| GlaxoSmithKline, LLC. | $13.65 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116280708 | CMS |
| Lilly USA, LLC | $13.67 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136152840 | CMS |
| Lilly USA, LLC | $13.67 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136171702 | CMS |
| Lilly USA, LLC | $14.60 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136158551 | CMS |
| Lilly USA, LLC | $15.38 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136158553 | CMS |
| Lilly USA, LLC | $16.54 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134968931 | CMS |
| Lilly USA, LLC | $14.42 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136171704 | CMS |
| Lilly USA, LLC | $15.99 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136162767 | CMS |
| Novo Nordisk Inc | $14.21 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096615132 | CMS |
| Novo Nordisk Inc | $14.20 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096891367 | CMS |
| Novo Nordisk Inc | $17.41 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097738582 | CMS |
| Novo Nordisk Inc | $22.29 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096605483 | CMS |
| Novo Nordisk Inc | $15.12 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097184420 | CMS |
| Novo Nordisk Inc | $19.15 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096577047 | CMS |
| Novo Nordisk Inc | $15.03 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096793336 | CMS |
| Novo Nordisk Inc | $17.53 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096713619 | CMS |
| Novo Nordisk Inc | $15.61 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096894185 | CMS |
| PFIZER INC. | $27.24 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131623510 | CMS |
| PFIZER INC. | $14.74 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131752724 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.